Abstract
When technetium 99m is bound to methylene diphosphonate, the resulting compound is called technetium 99m-MDP. Administered intravenously, as much as 60% of this substance will be taken up by the skeleton through a process called chemabsorption by which the tracer is actually incorporated into the calcium hydroxyapatite crystal matrix of bone or other calcium depositions. The remainder of the tracer is excreted via the urinary tract. Gallium, another radioactive material, is not used as a primary agent for bone scans now that MDP bone scanning is available (Fig. 37.1)
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAuthor information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Singh, H., Neutze, J.A. (2012). Radionucleotide Bone Imaging. In: Singh, H., Neutze, J. (eds) Radiology Fundamentals. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-0944-1_37
Download citation
DOI: https://doi.org/10.1007/978-1-4614-0944-1_37
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-0943-4
Online ISBN: 978-1-4614-0944-1
eBook Packages: MedicineMedicine (R0)